Supplementary Table 3 from Comparative Study on the Efficacy and Exposure of Molecular Target Agents in Non–small Cell Lung Cancer PDX Models with Driver Genetic Alterations

Supplementary Table 3(A)Establishment status by histological subtype(B)Establishment status by gene aberration.补充表3：(A) 按组织学亚型（histological subtype）划分的建系状态；(B) 按基因畸变（gene aberration）划分的建系状态。